Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC)
Abstract Hepatocellular carcinoma (HCC) stands as the predominant form of primary liver cancer, characterized by a dismal prognosis. Therapeutic options for advanced HCC remain sparse, with efficacy significantly hampered by the emergence of drug resistance. In parallel with research into novel phar...
Saved in:
| Main Authors: | Mingxuan Zhang, Ruiping Guo, Zhuhui Yuan, Hao Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Global Challenges |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/gch2.202400217 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diverting hepatic lipid fluxes with lifestyles revision and pharmacological interventions as a strategy to tackle steatotic liver disease (SLD) and hepatocellular carcinoma (HCC)
by: Davide Misceo, et al.
Published: (2024-12-01) -
Neoadjuvant therapy for hepatocellular carcinoma—priming precision innovations to transform HCC treatment
by: Kristin E. Goodsell, et al.
Published: (2025-03-01) -
Nanoparticles and the treatment of hepatocellular carcinoma
by: Zhang Ziyu, et al.
Published: (2024-12-01) -
Unlocking the potential of gold nanoparticles as a game-changer in the fight against hepatocellular carcinoma
by: Sarmistha Saha, et al.
Published: (2025-01-01) -
A Narrative Review on Functionalized Nanoparticles for the Treatment and Early Detection of Hepatocellular Carcinoma
by: Meda Cosma, et al.
Published: (2025-07-01)